Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Dementia Clinical Trials

A listing of Dementia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (117) clinical trials

To investigate the efficacy of 24 weeks of basmisanil treatment on cognitive function as measured by the MATRICS consensus cognitive battery (MCCB) neurocognitive composite score, in stable patients with cognitive impairment associated with schizophrenia (CIAS) treated with antipsychotics..  

Phase

The purpose of this study is to determine the safety and efficacy of TRx0237 8 mg/day in the treatment of subjects with mild Alzheimer's Disease compared to placebo.

Phase

Multi-center, randomized, double-blind, parallel-group,placebo-controlled study to evaluate the safety and tolerability, efficacy, and PK of 60 mg and 90 mg AD-35 administered QD during 6 months of double-blind treatment followed by a second 6 months of open-label treatment to subjects with mild to moderate AD.  

Phase

This is a Phase II, randomised, multi-centre, double-blind, placebo-controlled proof-of-concept study to assess the safety, tolerability and efficacy of oral Xanamem™ once daily in adult subjects with mild dementia due to AD.

Phase

This is a study for early to mild Alzheimer’s, testing the safety of LY3002813 with or without LY3202626 and any side effects from the study medicine. This study is also evaluating whether LY3002813 with or without LY3202626 can help slow the mental and functional changes of Alzheimer’s disease.

Phase

This study is being done to see whether an investigational drug called LY3303560 is safe and tolerable and whether it might work to help people with Alzheimer’s disease. “Investigational” means that the drug being tested has not been approved for routine clinical use or for the use described in this ...

Phase

If you or someone you love suffers from Mild Cognitive Impairment due to Alzheimer's Disease, or mild Alzheimer's Disease, you may be eligible to participate in a research study.

Phase

A research study is enrolling for those suffering from Mild to Cognitive Impairment due to Alzheimer's Disease.  

Phase

This is a randomized placebo-controlled trial in individuals with Parkinson's disease dementia to evaluate the safety and efficacy of three doses of a study drug in participants with mild-to-moderate Parkinson's disease dementia treated for 12 weeks.  

Phase